P2.01-12 A Phase I/II Trial of IO102 and Pembrolizumab With/Without Chemotherapy as First-line Treatment of Metastatic NSCLC by Provencio, M., Spicer, J., Garrido, P., Perez, J.M. Trigo, Viteri, S., Bosch-Barrera, J., Insa, A., Felip, E., De Castro Carpeno, J., Coart, E., Schmidt, E., Christiansen, A., Andersen, M. Hald, Zocca, M., Ehrnrooth, E., Paz-Aras, L.

Get full text